Stockreport

MIRA Pharmaceuticals Announces Ketamir-2's Oral Bioavailability Predicted to be 80% [Yahoo! Finance]

MIRA Pharmaceuticals, Inc.  (MIRA) 
PDF BALTIMORE Nov. 29, 2023 /PRNewswire/ -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), an innovative pre-clinical-stage pharmaceutical company foc [Read more]